https://thepharmadata.com/lupin-launches-ganirelix-acetate-injection-in-the-united-states/ 2024-02-17T05:56:05+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Lupin-Launches-Ganirelix-Acetate-Injectionth-in-e-United-States.webp https://thepharmadata.com/olezarsen-receives-orphan-drug-designation-from-u-s-fda-for-familial-chylomicronemia-syndrome/ 2024-02-17T05:51:22+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Olezarsen-receives-Orphan-Drug-designation-from-U.S.-FDA-for-familial-chylomicronemia-syndrome.webp https://thepharmadata.com/initiative-by-who-to-enhance-global-health-resilience-through-biomanufacturing-workforce-training/ 2024-02-17T05:46:35+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/WHO-Launches-Biomanufacturing-Workforce-Training.webp https://thepharmadata.com/revised-who-recommendations-for-managing-vector-borne-diseases-via-indoor-residual-spraying/ 2024-02-17T05:39:27+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Updated-WHO-guidance-for-controlling-vector-borne-diseases-through-indoor-residual-spraying.webp https://thepharmadata.com/who-unveils-guidelines-and-resources-to-improve-small-scale-water-supplies/ 2024-02-17T05:14:48+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/WHO-releases-guidelines-and-tools-to-enhance-small-water-supplies.webp https://thepharmadata.com/ono-and-numab-forge-collaboration-advancing-multi-specific-antibody-nm49-through-option-agreement/ 2024-02-17T05:01:36+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/ONO-and-Numab-Forge-Collaboration-Advancing-Multi-specific-Antibody-NM49-through-Option-Agreement.webp https://thepharmadata.com/sarepta-therapeutics-receives-u-s-fda-acceptance-for-efficacy-supplement-enabling-expansion-of-elevidys-indication/ 2024-02-17T04:56:23+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Sarepta-Therapeutics-Receives-U.S.-FDA-Acceptance-for-Efficacy-Supplement.webp https://thepharmadata.com/grifols-reveals-encouraging-phase-3-fibrinogen-clinical-trial-findings/ 2024-02-17T04:37:42+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Grifols-announces-positive-topline-phase-3-fibrinogen-clinical-trial-results.webp https://thepharmadata.com/biogen-received-european-commission-approval-for-skyclarys-omaveloxolone-the-first-therapy-to-treat-friedreichs-ataxia/ 2024-02-17T04:24:28+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Biogen-Received-European-Commission-Approval-for-SKYCLARYS-1.webp https://thepharmadata.com/gsk-finalizes-acquisition-of-aiolos-bio/ 2024-02-15T10:55:38+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Aiolos-Bio.webp https://thepharmadata.com/practical-two-day-fda-inspection-online-seminar-research-andmarkets-com/ 2024-02-15T10:49:32+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Research.webp https://thepharmadata.com/zoetis-reports-fourth-quarter-and-full-year-2023-results/ 2024-02-15T10:44:56+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Zoetis-Reports-Fourth-Quarter-and-Full-Year-2023-Results.webp https://thepharmadata.com/european-commission-approves-casgevy-for-sickle-cell-disease-and-beta-thalassemia/ 2024-02-15T10:36:12+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/European-Commission-Approves-CASGEVY%E2%84%A2-for-Sickle-Cell-Disease-and-Beta-Thalassemia.webp https://thepharmadata.com/fda-grants-priority-review-to-bristol-myers-squibbs-augtyro-repotrectinib-application-for-treating-patients-with-ntrk-positive-advanced-solid-tumors/ 2024-02-15T10:31:37+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/U.S.-Food-and-Drug-Administration.webp https://thepharmadata.com/abbvie-completes-acquisition-of-immunogen/ 2024-02-15T10:19:50+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/AbbVie-Completes-Acquisition-of-Immunogen.webp https://thepharmadata.com/lupin-launches-bromfenac-ophthalmic-solution-0-075-in-the-united-states/ 2024-02-15T10:14:25+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Lupin-Launches-Bromfenac-Ophthalmic-Solution-0.075-in-the-United-States.webp https://thepharmadata.com/give-yourself-credit-for-what-you-can-achieve/ 2024-02-15T10:09:49+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Give-yourself-credit-for-what-you-can-achieve.webp https://thepharmadata.com/european-commission-approves-casgevy-for-scd-and-tdt-treatment/ 2024-02-15T09:55:43+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/European-Commission-Approves-CASGEVY%E2%84%A2-for-SCD-and-TDT-TreatmentEuropean-Commission-Approves-CASGEVY%E2%84%A2-for-SCD-and-TDT-Treatment.webp https://thepharmadata.com/crispr-therapeutics-unveils-280-million-direct-offering/ 2024-02-15T09:54:38+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/CRISPR-Therapeutics-Unveils-280-Million-Direct-Offering.webp https://thepharmadata.com/new-findings-from-phase-3-trials-of-bimekizumab-in-moderate-to-severe-hidradenitis-suppurativa-to-be-revealed-at-ehsf-2024/ 2024-02-10T08:19:53+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Findings.webp https://thepharmadata.com/baxter-releases-financial-results-for-q4-and-fy-2023/ 2024-02-10T07:52:03+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Baxter-Releases-Financial-Results-for-Q4-and-FY-2023.webp https://thepharmadata.com/novartis-secures-approval-for-expanded-paediatric-chronic-heart-failure-indication-for-entrust-tablet-an-angiotensin-receptor-neprilysin-inhibitor-arni/ 2024-02-10T07:47:10+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Novartis-Secures-Approval-for-Expanded-Paediatric-Chronic-Heart-Failure-Indication-for-Entrust%C2%AE-Tablet-an-Angiotensin-Receptor-Neprilysin-Inhibitor-ARNI.webp https://thepharmadata.com/revamped-bon-curry-neo-line-otsuka-foods-introduces-five-enhanced-products-for-a-flavorful-relaunch-arriving-in-stores-on-march-4-2024/ 2024-02-10T07:38:34+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Revamped-Bon-Curry-NEO-Line-Otsuka-Foods-Introduces-Five-Enhanced-Products-for-a-Flavorful-Relaunch.webp https://thepharmadata.com/rsvvw-abstract-regarding-mrna-1345-official-statement/ 2024-02-10T07:38:13+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/RSVVW-Abstract-Regarding-mRNA-1345-Official-Statement.webp https://thepharmadata.com/biotech-and-autoloops-forge-partnership-for-advancing-car-t-cell-therapy-pipeline-and-scaling-late-stage-initiatives/ 2024-02-10T07:37:51+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/BioNTech-and-Autolus-Announce-Strategic-CAR-T-Cell-Therapy.webp https://thepharmadata.com/takeda-plans-prompt-commencement-of-global-phase-3-trials-for-tak-861-an-oral-orexin-agonist-in-narcolepsy-type-1-by-first-half-of-fiscal-year-2024/ 2024-02-10T07:37:07+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Global-Phase-3.webp https://thepharmadata.com/otsuka-and-jolly-good-initiate-distribution-of-faceduo-content-to-aid-families-supporting-individuals-with-severe-social-withdrawal/ 2024-02-10T07:31:00+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Otsuka-and-Jolly-Good-Initiate-Distribution-of-FACEDUO-Content-to-Aid-Families-Supporting-Individuals-with-Severe-Social-Withdrawal.webp https://thepharmadata.com/positive-results-for-mosunetuzumab-in-japanese-phase-i-study-meeting-primary-endpoint-for-relapsed-and-refractory-follicular-lymphoma-expansion-cohort/ 2024-02-10T06:22:57+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Lymphoma.webp https://thepharmadata.com/crovalimab-becomes-first-country-approved-in-china-for-treating-paroxysmal-nocturnal-haemoglobinuria/ 2024-02-10T05:47:24+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Crovalimab-Becomes-First-Country-Approved-in-China-for-Treating-Paroxysmal-Nocturnal-Hemoglobinuria.webp https://thepharmadata.com/michael-kleinemeier-to-serve-as-chairman-of-mercks-supervisory-board-until-the-2024-annual-general-meeting/ 2024-02-10T05:41:00+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Michael-Kleinemeier-to-Serve-as-Chairman-of-Mercks-Supervisory-Board-until-the-2024-Annual-General-Meeting.webp https://thepharmadata.com/lilly-treasurer-philip-johnson-announces-retirement/ 2024-02-10T05:33:33+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Lilly-Treasurer-Philip-Johnson-Announces-Retirement.webp https://thepharmadata.com/sanofis-scientific-leadership-in-inflammatory-diseases-showcased-with-new-data-at-aaaai-presentation/ 2024-02-10T05:32:52+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/Sanofis-Scientific-Leadership-in-Inflammatory-Diseases-Showcased-with-New-Data-at-AAAAI-Presentation.webp https://thepharmadata.com/recent-data-reveals-nexviazyme-exhibits-clinical-safety-benefits-and-long-lasting-efficacy-across-diverse-pompe-disease-patient-cohorts/ 2024-02-07T05:25:00+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-artem-podrez-4492050-2.webp https://thepharmadata.com/addressing-disparities-in-cancer-care-american-cancer-society-and-pfizer-unveil-a-15-million-three-year-initiative-to-overcome-barriers/ 2024-02-07T05:15:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/breast-cancer.webp https://thepharmadata.com/novartis-enhances-oncology-portfolio-through-acquisition-of-morphosys-ag-at-eur-68-per-share-totaling-eur-2-7-billion-in-cash/ 2024-02-07T05:11:47+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-pixabay-534229-1.webp https://thepharmadata.com/acquisition-of-elancos-aqua-business-by-merck-animal-health/ 2024-02-07T05:05:10+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-freestocksorg-4074725.webp https://thepharmadata.com/novo-nordisks-acquisition-of-three-fill-finish-sites-from-novo-holdings-a-s-in-conjunction-with-the-catalent-inc-deal/ 2024-02-07T04:46:32+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-karolina-grabowska-8107287.webp https://thepharmadata.com/lillys-robust-financial-performance-in-q4-2023-and-outlook-for-2024-revealed/ 2024-02-07T04:38:55+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-fauxels-3183153.webp https://thepharmadata.com/encouraging-outcomes-in-japan-phase-iii-study-of-acoramidis-for-transthyretin-mediated-amyloid-cardiomyopathy-in-adults-align-with-global-attribute-cm-phase-iii-trial/ 2024-02-03T07:41:20+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-chokniti-khongchum-3938023.webp https://thepharmadata.com/extended-study-highlights-persistent-retinal-drying-and-vision-enhancement-with-roches-vabysmo-in-retinal-vein-occlusion/ 2024-02-03T07:02:02+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-leonid-danilov-4121712.webp https://thepharmadata.com/fda-grants-fast-track-designation-to-biontech-and-dualitybio-for-next-generation-antibody-drug-conjugate-candidate-bnt325-db-1305/ 2024-02-03T06:20:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/drug.webp https://thepharmadata.com/biogen-plans-resource-realignment-for-alzheimers-disease-franchise/ 2024-02-03T06:20:09+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-matthias-zomer-339620.webp https://thepharmadata.com/european-medicines-agency-validates-marketing-authorization-application-for-tisotumab-vedotin-in-treating-recurrent-or-metastatic-cervical-cancer/ 2024-02-03T05:52:06+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-anna-tarazevich-8428356.webp https://thepharmadata.com/labcorp-introduces-innovative-test-for-assessing-risk-and-predicting-severity-of-preeclampsia-in-expectant-mothers/ 2024-02-03T05:45:28+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-leah-kelley-952597.webp https://thepharmadata.com/verification-of-gamma-wave-synchronization-in-the-human-brain-via-auditory-stimulation-academic-session-at-neuroscience-2023-in-the-united-states/ 2024-02-03T05:39:20+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-shvets-production-7203727.webp https://thepharmadata.com/bio-techne-unveils-fiscal-2024-second-quarter-financial-performance/ 2024-02-03T05:34:42+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-fauxels-3183153.webp https://thepharmadata.com/advanced-cell-diagnostics-by-bio-techne-establishes-a-new-benchmark-in-spatial-biology-with-protease-free-rnascope-multiomics/ 2024-02-03T05:30:32+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/TB-diagnostics.webp https://thepharmadata.com/teva-plans-api-business-divestment-as-a-key-element-of-growth-oriented-strategy/ 2024-02-03T05:20:50+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-helena-lopes-933964.webp https://thepharmadata.com/grifols-appoints-new-senior-leadership-team/ 2024-02-03T05:12:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Leadership.webp https://thepharmadata.com/staying-alert-and-taking-precautions-during-lunar-new-year-celebrations-amidst-avian-influenza-concerns/ 2024-02-03T05:05:48+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-ketut-subiyanto-4472976.webp https://thepharmadata.com/rising-global-cancer-cases-highlight-increasing-demand-for-healthcare-services/ 2024-02-03T05:01:12+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Cancer-Vaccine.webp https://thepharmadata.com/atara-biotherapeutics-and-pierre-fabre-laboratories-release-phase-3-allele-tab-cel-results-in-the-lancet-oncology/ 2024-02-01T10:20:17+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-mikhail-nilov-9243557.webp https://thepharmadata.com/rohto-pharmaceutical-forges-global-aesthetics-market-entry-through-long-term-strategic-and-equity-partnership-with-ema-aesthetics/ 2024-02-01T10:15:52+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/partnerships.jpg https://thepharmadata.com/vivet-therapeutics-secures-eur-4-9-million-to-progress-development-of-gene-therapy-targeting-cerebrotendinous-xanthomatosis/ 2024-02-01T10:13:03+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-markus-spiske-3970330.webp https://thepharmadata.com/merck-inaugurates-its-maiden-digital-hub-in-singapore/ 2024-02-01T10:03:47+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-gul-isik-5576311-1.webp https://thepharmadata.com/newly-elected-board-members-at-e-merck-kg/ 2024-02-01T10:00:08+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-tara-winstead-8850709.webp https://thepharmadata.com/regeneron-establishes-regeneron-cell-medicines-through-acquisition-of-2seventy-bio-platforms-and-development-programs/ 2024-02-01T09:53:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Medicines-_2_.webp https://thepharmadata.com/fda-approves-kites-manufacturing-process-change-leading-to-faster-turnaround-time-for-yescarta-car-t-cell-therapy/ 2024-02-01T09:47:12+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-edmond-dantes-8553864.webp https://thepharmadata.com/gilead-and-arcus-revise-collaboration-agreement-and-equity-investment-terms/ 2024-02-01T09:42:10+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-pixabay-261621.webp https://thepharmadata.com/vertex-reports-favorable-outcomes-from-phase-3-trials-of-vx-548-for-managing-moderate-to-severe-acute-pain/ 2024-02-01T09:39:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/report-_2_.webp https://thepharmadata.com/bristol-myers-squibbs-breyanzi-granted-regulatory-acceptance-in-the-u-s-and-japan-for-relapsed-or-refractory-follicular-lymphoma-and-relapsed-or-refractory-mantle-cell-lymphoma/ 2024-02-01T09:34:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lymphoma.webp https://thepharmadata.com/sanofi-achieves-robust-sales-and-business-eps-growth-at-constant-exchange-rates-fueled-by-successful-product-launches-and-progress-in-immunology-pipeline/ 2024-02-01T09:30:48+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/raises-sales.webp https://thepharmadata.com/priority-review-granted-in-the-us-for-enhertu-in-patients-with-metastatic-her2-positive-solid-tumors/ 2024-02-01T09:23:18+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-tima-miroshnichenko-6010783.webp https://thepharmadata.com/eisai-submits-new-drug-application-for-mecobalamin-ultrahigh-dose-formulation-in-japan-for-the-indication-of-amyotrophic-lateral-sclerosis/ 2024-02-01T09:18:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/drug.webp https://thepharmadata.com/sustained-retinal-drying-and-vision-improvements-in-retinal-vein-occlusion-rvo-demonstrated-by-roches-vabysmo/ 2024-02-01T09:17:53+00:00 https://thepharmadata.com/wp-content/uploads/2024/02/pexels-leonid-danilov-4121712.webp https://thepharmadata.com/novo-nordisks-sales-increased-by-31-in-danish-kroner-and-by-36-at-constant-exchange-rates-to-dkk-232-3-billion-in-2023/ 2024-02-01T09:09:20+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-arina-krasnikova-6016350.webp https://thepharmadata.com/notice-of-investment-agreement-with-niremia-collective/ 2024-01-27T06:12:02+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-david-mcbee-730547.webp https://thepharmadata.com/objectivehealth-announces-strategic-growth-investment-from-vitruvian-partners/ 2024-01-27T06:06:49+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/abbvie-expands-biologics-manufacturing-capacity-with-a-223-million-investment-in-singapore-manufacturing-site/ 2024-01-27T05:54:50+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Investment-scaled.webp https://thepharmadata.com/lonza-delivers-solid-2023-performance-with-10-9-cer-sales-growth-and-29-8-core-ebitda-margin/ 2024-01-27T05:54:20+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-arina-krasnikova-6016350.webp https://thepharmadata.com/merck-and-china-resources-power-enter-into-long-term-green-power-agreement-to-reduce-carbon-footprint-in-china/ 2024-01-27T05:39:38+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-pixabay-261621.webp https://thepharmadata.com/the-ohio-state-university-wexner-medical-center-and-cvs-accountable-care-collaborate-to-improve-medicare-beneficiary-care-coordination-in-ohio/ 2024-01-27T05:35:50+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-pixabay-159775-1.webp https://thepharmadata.com/bristol-myers-squibb-receives-positive-chmp-opinion-for-car-t-cell-therapy-abecma-in-earlier-lines-of-therapy-for-triple-class-exposed-relapsed-and-refractory-multiple-myeloma/ 2024-01-27T05:30:14+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-anna-tarazevich-8110797-1.webp https://thepharmadata.com/dupixent-fda-approved-as-first-and-only-treatment-indicated-for-children-aged-1-year-and-older-with-eosinophilic-esophagitis/ 2024-01-27T05:26:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/european-medicines-agency-validates-type-ii-variation-application-for-padcev-with-keytruda-for-first-line-treatment-of-advanced-bladder-cancer/ 2024-01-27T05:24:31+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.jpg https://thepharmadata.com/mercks-keytruda-significantly-improved-disease-free-survival-as-adjuvant-therapy-versus-observation-in-high-risk-patients-with-localized-muscle-invasive-and-locally-advanced-urothelial/ 2024-01-27T05:21:16+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Adult-Patients.webp https://thepharmadata.com/allergan-aesthetics-showcases-commitment-to-individuality-innovation-and-integrity-at-imcas-world-congress-2024/ 2024-01-27T05:16:35+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-cottonbro-studio-6865181.webp https://thepharmadata.com/application-for-regulatory-approval-of-aflibercept-8-mg-accepted-in-china/ 2024-01-25T11:40:06+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Approval.webp https://thepharmadata.com/bayer-appoints-nelson-ambrogio-as-new-head-of-radiology-business-at-pharmaceuticals-division/ 2024-01-25T11:38:06+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Pharmaceuticals.webp https://thepharmadata.com/top-40-high-school-scientists-in-prestigious-regeneron-science-talent-search-to-compete-for-1-8-million-in-awards/ 2024-01-25T11:34:03+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-cottonbro-studio-6565255.webp https://thepharmadata.com/bristol-myers-squibb-completes-acquisition-of-mirati-therapeutics-strengthening-and-diversifying-oncology-portfolio/ 2024-01-25T11:30:26+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-ivan-samkov-6436272.webp https://thepharmadata.com/opdivo-in-combination-with-cabometyx-demonstrates-long-term-survival-benefits-after-four-years-of-follow-up-in-the-checkmate-9er-trial-in-first-line-advanced-renal-cell-carcinoma/ 2024-01-25T11:25:44+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-fayette-reynolds-ms-11198503.webp https://thepharmadata.com/sanofi-to-acquire-inhibrx-inc-adding-potential-best-in-class-rare-disease-asset-for-alpha-1-antitrypsin-deficiency-to-pipeline/ 2024-01-25T11:20:49+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-edward-jenner-4031818.webp https://thepharmadata.com/alle-by-allergan-aesthetics-is-the-leading-aesthetics-loyalty-rewards-program-in-the-u-s/ 2024-01-25T11:16:41+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-cottonbro-studio-6803525.webp https://thepharmadata.com/positive-phase-1-2-clinical-trial-data-for-an-investigational-gene-therapy-for-genetic-hearing-loss-to-be-presented-at-the-association-for-research-in-otolaryngology-2024-midwinter-meeting/ 2024-01-25T11:13:07+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting-2.webp https://thepharmadata.com/biogen-appoints-adam-keeney-as-head-of-corporate-development/ 2024-01-20T13:30:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Appoints.webp https://thepharmadata.com/imfinzi-plus-transarterial-chemoembolization-and-bevacizumab-reduced-the-risk-of-disease-progression-or-death-by-23-vs-tace-in-liver-cancer-eligible-for-embolization/ 2024-01-20T05:22:52+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/liver-cancer.webp https://thepharmadata.com/noom-glp-1-companion-to-add-muscle-defense-to-promote-safer-glp-1-use/ 2024-01-20T05:17:26+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-samer-daboul-2080544.webp https://thepharmadata.com/edgewise-therapeutics-announces-pricing-of-240-million-underwritten-offering-of-common-stock/ 2024-01-20T05:12:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/eisai-listed-as-a-global-100-most-sustainable-corporation-for-the-eighth-time/ 2024-01-20T05:08:09+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-karolina-grabowska-8107287.webp https://thepharmadata.com/antiepileptic-drug-fycompa-injection-formulation-approved-in-japan/ 2024-01-20T05:03:47+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-rfstudio-3825529.webp https://thepharmadata.com/wuxi-biologics-granted-u-s-patent-for-proprietary-bispecific-antibody-technology-platform-wuxibodytm/ 2024-01-20T05:00:28+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/biotechnology.webp https://thepharmadata.com/new-eylea-8-mg-approved-in-japan/ 2024-01-20T04:53:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/zoetis-wins-2024-catalyst-award/ 2024-01-20T04:44:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-nataliya-vaitkevich-6532373.webp https://thepharmadata.com/bristol-myers-squibb-data-at-asco-gu-2024-showcase-transformative-research-in-the-treatment-of-genitourinary-cancers/ 2024-01-20T04:40:47+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-tima-miroshnichenko-6010929.webp https://thepharmadata.com/novartis-lutathera-significantly-reduced-risk-of-disease-progression-or-death-by-72-as-first-line-treatment-for-patients-with-advanced-gastroenteropancreatic-neuroendocrine-tumors/ 2024-01-20T04:36:51+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Adult-Patients.webp https://thepharmadata.com/imfinzi-plus-transarterial-chemoembolisation-and-bevacizumab-reduced-the-risk-of-disease-progression-or-death-by-23-vs-tace-in-liver-cancer-eligible-for-embolisation/ 2024-01-20T04:34:45+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.jpg https://thepharmadata.com/voydeya-granted-first-ever-regulatory-approval-in-japan-for-adults-with-pnh-to-be-used-in-combination-with-c5-inhibitor-therapy/ 2024-01-20T04:31:04+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-jopwell-2422294.webp https://thepharmadata.com/u-s-fda-approves-takedas-hyqvia-as-maintenance-therapy-in-adults-with-chronic-inflammatory-demyelinating-polyneuropathy/ 2024-01-17T06:21:23+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-danik-prihodko-8219158.webp https://thepharmadata.com/dupixent-u-s-label-updated-with-data-further-supporting-use-in-atopic-dermatitis-with-moderate-to-severe-hand-and-foot-involvement/ 2024-01-17T06:10:01+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-teemu-r-1840315.webp https://thepharmadata.com/swissmedic-authorises-csls-hemgenixas-first-gene-therapy-for-hemophilia-b/ 2024-01-17T06:05:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Gene-Therapy.webp https://thepharmadata.com/european-commission-approves-roches-tecentriq-sc-the-eus-first-pd-l1-cancer-immunotherapy-subcutaneous-injection-for-multiple-cancer-types/ 2024-01-17T05:58:12+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-edmond-dantes-8553864.webp https://thepharmadata.com/icon-issues-financial-guidance-for-full-year-2024/ 2024-01-13T07:18:56+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-pixabay-164527.webp https://thepharmadata.com/biotech-companies-to-increase-rd-spend-but-highlight-complexity-of-clinical-trials-icon/ 2024-01-13T07:14:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-sevenstorm-juhaszimrus-443383.webp https://thepharmadata.com/icon-wins-industry-accolades-from-time-magazine-forbes-and-financial-times-in-second-half-of-2023-2/ 2024-01-13T06:45:32+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-helena-lopes-711009.webp https://thepharmadata.com/bayers-askbio-initiates-phase-ii-gene-phit-trial-in-congestive-heart-failure-chf/ 2024-01-13T06:37:16+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-chokniti-khongchum-3938023.webp https://thepharmadata.com/bayer-announces-key-leadership-changes-for-its-crop-science-division/ 2024-01-13T06:33:23+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/leqembi-approved-for-the-treatment-of-alzheimers-disease-in-china/ 2024-01-13T06:20:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment.webp https://thepharmadata.com/nucala-approved-in-china-for-use-in-severe-asthma-with-an-eosinophilic-phenotype/ 2024-01-13T06:16:24+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-edmond-dantes-8553864.webp https://thepharmadata.com/gsk-enters-agreement-to-acquire-aiolos-bio/ 2024-01-13T06:14:07+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/agreements.webp https://thepharmadata.com/aetna-helps-treat-childhood-vision-disorders-with-75000-donation-to-plano-child-development-center/ 2024-01-13T05:50:21+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-pixabay-220455.webp https://thepharmadata.com/vertex-announces-approval-of-first-crispr-cas9-gene-edited-therapy-casgevy-for-the-treatment-of-sickle-cell-disease-and-transfusion-dependent-beta-thalassemia-in-kingdom-of-saudi-arabia/ 2024-01-13T05:44:24+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-karolina-grabowska-8107287.webp https://thepharmadata.com/pfizer-recommends-shareholders-reject-the-below-market-mini-tender-offer-by-trc-capital-investment-corporation/ 2024-01-13T05:38:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Investment-scaled.webp https://thepharmadata.com/tivdak-supplemental-biologics-license-application-accepted-for-priority-review-by-fda-for-patients-with-recurrent-or-metastatic-cervical-cancer/ 2024-01-13T05:35:45+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-anna-tarazevich-8428356.webp https://thepharmadata.com/fda-approves-mercks-keytruda-plus-chemoradiotherapy-as-treatment-for-patients-with-figo-2014-stage-iii-iva-cervical-cancer/ 2024-01-13T05:18:59+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-edmond-dantes-8553864-1.webp https://thepharmadata.com/abbvie-launches-produodopa-for-people-living-with-advanced-parkinsons-disease-in-the-european-union-2/ 2024-01-13T05:13:38+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-pawel-l-1245055.webp https://thepharmadata.com/abbvie-launches-produodopa-for-people-living-with-advanced-parkinsons-disease-in-the-european-union/ 2024-01-09T11:27:44+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-karolina-grabowska-8107287.webp https://thepharmadata.com/lutikizumab-showed-positive-results-in-a-phase-2-trial-of-adults-with-moderate-to-severe-hidradenitis-suppurativa-as-program-advances-to-phase-3/ 2024-01-09T11:25:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-chokniti-khongchum-3938023.webp https://thepharmadata.com/combine-3-phase-3a-trial-successfully-completed-with-once-weekly-icosema-demonstrating-non-inferior-reduction-in-hba1c-versus-daily-basal-bolus-treatment-in-people-with-type-2-diabetes/ 2024-01-09T11:21:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/diabetes.webp https://thepharmadata.com/clarametyx-biosciences-announces-33m-series-a-financing-to-advance-anti-biofilm-biologics-for-serious-bacterial-infections/ 2024-01-06T06:05:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/bio-techne-to-showcase-cell-and-gene-therapy-manufacturing-tools-at-phacilitate-advanced-therapies-week-2024/ 2024-01-06T06:03:54+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-anete-lusina-5240677.webp https://thepharmadata.com/sail-biomedicines-provides-update-on-research-with-cystic-fibrosis-foundation-and-pioneering-medicines/ 2024-01-06T06:03:33+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Medicines-_2_.webp https://thepharmadata.com/boehringer-ingelheim-licenses-a-new-compound-as-part-of-its-commitment-to-people-living-with-fibro-inflammatory-diseases-fromkyowa-kirin/ 2024-01-06T05:56:26+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-pawel-l-1245055.webp https://thepharmadata.com/askbio-announces-initiation-of-phase-2-genephit-trial-in-congestive-heart-failure/ 2024-01-06T05:36:38+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-karolina-grabowska-8107287.webp https://thepharmadata.com/askbio-phase-ib-trial-of-ab-1005-gene-therapy-in-patients-with-parkinsons-disease-meets-primary-endpoint-2/ 2024-01-06T05:33:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-pavel-danilyuk-7653310.webp https://thepharmadata.com/novartis-expands-production-of-pluvicto-with-addition-of-its-largest-and-most-advanced-radioligand-therapy-manufacturing-facility-in-indianapolis/ 2024-01-06T05:29:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-life-of-pix-2391.webp https://thepharmadata.com/merck-expands-colorectal-cancer-portfolio-through-licensing-agreement-with-inspirna/ 2024-01-06T05:29:12+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/agreements.webp https://thepharmadata.com/merck-announces-phase-3-trial-initiations-for-four-investigational-candidates-from-its-promising-hematology-and-oncology-pipeline/ 2024-01-06T05:13:36+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/abbvie-and-umoja-biopharma-announce-strategic-collaboration-to-develop-novel-in-situ-car-t-cell-therapies/ 2024-01-06T05:02:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/novo-nordisk-enters-into-research-collaborations-with-omega-therapeutics-and-cellarity-on-novel-treatment-approaches-for-cardiometabolic-diseases/ 2024-01-06T05:00:59+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Treatment-_4_.webp https://thepharmadata.com/innate-pharma-strengthens-leadership-and-appoints-two-new-members-to-its-executive-board/ 2024-01-04T11:22:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Appoints-1.webp https://thepharmadata.com/depixus-launches-technology-access-program-with-first-magna-one-instrument-placement/ 2024-01-04T11:19:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/programs.webp https://thepharmadata.com/resalis-therapeutics-raises-e10-million-series-a-to-complete-first-clinical-trial-for-res-010-in-obesity/ 2024-01-04T11:18:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-chokniti-khongchum-3938023.webp https://thepharmadata.com/global-botulinum-toxin-in-urology-market-size-share-trends-analysis-report-2023-2030/ 2024-01-04T11:16:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/report-_2_.webp https://thepharmadata.com/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c/ 2024-01-04T11:06:51+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Application-2.webp https://thepharmadata.com/askbio-phase-ib-trial-of-ab-1005-gene-therapy-in-patients-with-parkinsons-disease-meets-primary-endpoint/ 2024-01-04T10:46:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Adult-Patients.webp https://thepharmadata.com/esperion-and-daiichi-sankyo-europe-announce-125-million-amendment-to-their-collaboration-including-resolution-of-pending-litigation/ 2024-01-04T10:40:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-brett-sayles-5326740.webp https://thepharmadata.com/european-medicines-agency-validates-bristol-myers-squibbs-application-for-repotrectinib-for-the-treatment-of-locally-advanced-or-metastatic-ros1-positive-non-small-cell-lung-cancer-and-ntrk-p/ 2024-01-04T10:34:02+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lung-cancer.webp https://thepharmadata.com/beyfortus-approved-in-china-for-the-prevention-of-rsv-disease-in-infants/ 2024-01-04T10:09:28+00:00 https://thepharmadata.com/wp-content/uploads/2024/01/pexels-edmond-dantes-8553864.webp https://thepharmadata.com/roche-enters-into-a-definitive-agreement-to-acquire-lumiradxs-point-of-care-technology-combining-multiple-diagnostic-modalities-on-a-single-platform/ 2023-12-30T05:13:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/agreements.webp https://thepharmadata.com/statement-following-the-thirty-seventh-meeting-of-the-ihr-emergency-committee-for-polio/ 2023-12-27T05:36:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Meeting-_4_.webp https://thepharmadata.com/hansoh-pharmas-saint-luolai-is-added-to-the-national-reimbursement-drug-list-opening-a-new-chapter-in-the-long-term-treatment-for-ckd-renal-anemia-in-china/ 2023-12-27T05:28:40+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-energepiccom-110473.webp https://thepharmadata.com/bristol-myers-squibb-adds-premier-radiopharmaceutical-platform-with-acquisition-of-rayzebio/ 2023-12-27T04:59:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Pharmaceuticals.webp https://thepharmadata.com/bristol-myers-squibb-strengthens-neuroscience-portfolio-with-acquisition-of-karuna-therapeutics/ 2023-12-27T04:53:30+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/THERAPEUTICS.webp https://thepharmadata.com/wainua-granted-first-ever-regulatory-approval-in-the-us-for-the-treatment-of-adults-with-polyneuropathy-of-hereditary-transthyretin-mediated-amyloidosis/ 2023-12-27T04:49:03+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Treatment-_4_.webp https://thepharmadata.com/patritumab-deruxtecan-granted-priority-review-in-the-u-s-for-certain-patients-with-previously-treated-locally-advanced-or-metastatic-egfr-mutated-non-small-cell-lung-cancer/ 2023-12-27T04:45:49+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-anna-tarazevich-8016901.webp https://thepharmadata.com/novo-nordisk-invests-more-than-16-billion-danish-kroner-in-expansion-of-production-facilities-in-chartres-france-2/ 2023-12-27T04:41:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-pixabay-257904.webp https://thepharmadata.com/biomarin-announces-governance-enhancements-and-value-creation-initiatives/ 2023-12-21T10:20:04+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/execution-of-sub-license-agreement-from-ping-an-shionogi-hong-kong-to-juniper-therapeutics-and-sar-approval-in-singapore-regarding-ensitrelvir-fumaric-acid-a-treatment-drug-for-the-novel-coronavirus/ 2023-12-21T06:55:02+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/agreements.webp https://thepharmadata.com/ema-recommends-arpraziquantel-for-treatment-of-schistosomiasis-in-preschool-aged-children/ 2023-12-21T06:46:49+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Treatment-_4_.webp https://thepharmadata.com/padcev-with-keytruda-approved-by-fda-as-the-first-and-only-adc-plus-pd-1-to-treat-advanced-bladder-cancer/ 2023-12-21T06:43:12+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/icon-wins-industry-accolades-from-time-magazine-forbes-and-financial-times-in-second-half-of-2023/ 2023-12-21T06:20:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-helena-lopes-711009.webp https://thepharmadata.com/biontech-achieves-milestone-at-mrna-based-vaccine-manufacturing-site-in-rwanda/ 2023-12-21T06:13:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-life-of-pix-2391.webp https://thepharmadata.com/argenx-reports-topline-results-from-address-study-of-efgartigimod-sc-in-pemphigus/ 2023-12-21T06:08:50+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/report-_2_.webp https://thepharmadata.com/two-phase-3-trials-of-datopotamab-deruxtecan-plus-durvalumabinitiated-in-patients-across-two-breast-cancer-subtypes/ 2023-12-21T05:55:45+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/breast-cancer-1.webp https://thepharmadata.com/decision-to-invest-over-20-billion-yen-in-bio-drug-substance-manufacturing-building-uk3-to-expand-its-production-capacity-and-towards-realizing-halogenated-hydrocarbon-free/ 2023-12-21T05:23:48+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-david-mcbee-730547.webp https://thepharmadata.com/chugai-venture-fund-starts-investment-activities-in-drug-discovery-start-ups-to-accelerate-innovation/ 2023-12-21T05:19:06+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Investment-scaled.webp https://thepharmadata.com/gsk-enters-exclusive-license-agreement-with-hansoh-for-hs-20093/ 2023-12-21T05:14:17+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/agreements.webp https://thepharmadata.com/aetna-better-health-of-illinois-and-mae-health-announce-partnership-to-give-members-access-to-local-doulas-for-pregnancy-and-postpartum-health-support/ 2023-12-21T05:05:06+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/partnerships.webp https://thepharmadata.com/gilead-and-compugen-announce-exclusive-license-agreement-for-novel-pre-clinical-immunotherapy-program/ 2023-12-20T10:54:16+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-brett-sayles-5326740.webp https://thepharmadata.com/fda-grants-priority-review-to-xolair-for-children-and-adults-with-food-allergies-based-on-positive-national-institutes-of-health-phase-iii-study-results/ 2023-12-20T10:46:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-mikhail-nilov-8307520-1.webp https://thepharmadata.com/lilly-extends-tender-offer-to-acquire-point-biopharma-to-dec-22-2023/ 2023-12-20T10:42:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-anna-shvets-3683051.webp https://thepharmadata.com/ema-gives-positive-opinion-to-fexinidazole-winthrop-as-first-oral-treatment-of-acute-form-of-sleeping-sickness-found-in-east-and-southern-africa/ 2023-12-16T07:23:11+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-rdne-stock-project-6129504.webp https://thepharmadata.com/amgen-announces-executive-appointments-to-accelerate-innovation/ 2023-12-16T07:13:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/amgen-to-sponsor-the-irish-open/ 2023-12-16T06:48:27+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-dio-hasbi-saniskoro-3280130-1.webp https://thepharmadata.com/fda-grants-priority-review-to-amgens-tarlatamab-application-for-advanced-small-cell-lung-cancer/ 2023-12-16T06:44:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Application.webp https://thepharmadata.com/vertex-receives-chmp-positive-opinion-for-the-first-crispr-cas9-gene-edited-therapy-casgevy-exagamglogene-autotemcel-for-the-treatment-of-sickle-cell-disease-and-transfusion-dependen/ 2023-12-16T06:36:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-markus-spiske-3970330.webp https://thepharmadata.com/vertex-announces-positive-results-from-phase-2-study-of-vx-548-for-the-treatment-of-painful-diabetic-peripheral-neuropathy/ 2023-12-16T06:33:01+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/positive-chmp-opinion-by-ema-for-arpraziquantel-to-treat-schistosomiasis-in-preschool-aged-children/ 2023-12-16T06:26:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-sharefaith-1231215.webp https://thepharmadata.com/chugai-files-for-additional-indication-of-alecensa-for-postoperative-adjuvant-therapy-for-alk-fusion-gene-positive-non-small-cell-lung-cancer/ 2023-12-16T06:19:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-anna-tarazevich-8016901.webp https://thepharmadata.com/takeda-receives-positive-chmp-opinion-for-hyqvia-as-maintenance-therapy-in-patients-with-chronic-inflammatory-demyelinating-polyneuropathy-cidp/ 2023-12-16T06:16:51+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-pavel-danilyuk-7653310.webp https://thepharmadata.com/chmp-issues-positive-opinion-for-biogens-skyclarys-the-first-therapy-to-treat-friedreichs-ataxia-a-rare-neurodegenerative-disease/ 2023-12-16T06:12:37+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-alex-green-5692699.webp https://thepharmadata.com/zurzuvae-zuranolone-civ-a-landmark-oral-treatment-for-women-with-postpartum-depression-ppd-is-now-available-in-the-u-s/ 2023-12-16T06:07:58+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment-_2_-scaled.webp https://thepharmadata.com/padcev-enfortumab-vedotin-ejfv-with-keytruda-pembrolizumab-approved-by-fda-as-the-first-and-only-adc-plus-pd-1-to-treat-advanced-bladder-cancer/ 2023-12-16T06:05:25+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Cancer-Vaccine.webp https://thepharmadata.com/pfizer-receives-all-required-regulatory-approvals-to-complete-the-acquisition-of-seagen/ 2023-12-16T06:03:08+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Approvals.webp https://thepharmadata.com/pfizer-completes-acquisition-of-seagen/ 2023-12-16T05:01:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/bluebird-bio-details-plans-for-the-commercial-launch-of-lyfgenia-gene-therapy-for-patients-ages-12-and-older-with-sickle-cell-disease-and-a-history-of-vaso-occlusive-events/ 2023-12-09T06:03:33+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-pavel-danilyuk-7653310.webp https://thepharmadata.com/ipa-announces-closing-of-1-265-million-public-offering-of-common-shares/ 2023-12-09T05:57:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/merck-and-eisai-provide-update-on-phase-3-leap-001-trial-evaluating-keytruda-pembrolizumab-plus-lenvima-lenvatinib-as-first-line-treatment-for-patients-with-advanced-or-recurrent-endom/ 2023-12-09T05:52:31+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment.webp https://thepharmadata.com/merck-announces-keylynk-008-trial-evaluating-keytruda-pembrolizumab-plus-lynparza-olaparib-for-patients-with-metastatic-squamous-non-small-cell-lung-cancer-to-stop-for-futility/ 2023-12-09T05:38:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-anna-tarazevich-8016901.webp https://thepharmadata.com/merck-announces-findings-from-phase-2-keyvibe-002-trial-evaluating-an-investigational-coformulation-of-vibostolimab-and-pembrolizumab-in-previously-treated-patients-with-metastatic-non-small-cell-lung/ 2023-12-09T05:35:02+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Cancer-Vaccine.webp https://thepharmadata.com/roches-kadcyla-is-the-first-targeted-therapy-to-show-significant-overall-survival-benefit-in-people-with-her2-positive-early-stage-breast-cancer-with-residual-invasive-disease-after-neoadjuvant-trea/ 2023-12-09T05:32:27+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Treatment-_4_.webp https://thepharmadata.com/roches-inavolisib-combination-reduces-the-risk-of-disease-progression-by-57-in-people-with-advanced-hormone-receptor-positive-her2-negative-breast-cancer-with-a-pik3ca-mutation/ 2023-12-09T05:28:50+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/breast-cancer.webp https://thepharmadata.com/latest-novartis-kisqali-natalee-analysis-reinforces-25-reduction-in-risk-of-recurrence-across-broad-population-of-patients-with-early-breast-cancer-supports-regulatory-submissions/ 2023-12-09T05:25:57+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/breast-cancer-1.webp https://thepharmadata.com/european-commission-approves-pfizers-elrexfio-for-relapsed-and-refractory-multiple-myeloma/ 2023-12-09T05:24:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/sanofi-pipeline-transformation-to-accelerate-growth-driven-by-record-number-of-potential-blockbuster-launches-paving-the-way-to-industry-leadership-in-immunology/ 2023-12-09T05:21:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Leadership.webp https://thepharmadata.com/vertex-and-crispr-therapeutics-announce-us-fda-approval-of-casgevy-exagamglogene-autotemcel-for-the-treatment-of-sickle-cell-disease/ 2023-12-09T05:16:33+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Approval.webp https://thepharmadata.com/bayer-and-salus-optima-partner-on-ai-enabled-healthy-aging-journey/ 2023-12-09T05:06:08+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Partnership-_2_.webp https://thepharmadata.com/takeda-and-the-new-york-academy-of-sciences-announce-2024-innovators-in-science-award-winners/ 2023-12-06T07:00:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-nataliya-vaitkevich-6532373.webp https://thepharmadata.com/new-global-survey-finds-widespread-misunderstandings-about-shingles-despite-its-lifetime-prevalence/ 2023-12-06T06:46:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/survey.webp https://thepharmadata.com/merck-launches-first-ever-ai-solution-to-integrate-drug-discovery-and-synthesis/ 2023-12-06T06:26:49+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/drug.webp https://thepharmadata.com/merck-strengthens-oncology-portfolio-through-commercialization-agreement-with-abbisko-for-phase-iii-asset-pimicotinib/ 2023-12-06T06:24:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/agreements.webp https://thepharmadata.com/vertex-appoints-nancy-thornberry-to-its-board-of-directors/ 2023-12-06T06:15:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Appoints-_2_.webp https://thepharmadata.com/cvs-health-highlights-path-to-accelerating-long-term-growth-through-building-a-world-of-health-around-every-consumer/ 2023-12-06T06:12:13+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-lumn-327882-1.webp https://thepharmadata.com/gileads-leadership-in-metastatic-breast-cancer-showcased-with-new-trodelvy-data-at-san-antonio-breast-cancer-symposium-2023/ 2023-12-06T06:08:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Conference.webp https://thepharmadata.com/sanofis-consumer-healthcare-unit-launches-the-shared-care-collective-an-advisory-group-working-to-advance-sustainability/ 2023-12-06T06:04:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/12/pexels-total-shape-2383010.webp https://thepharmadata.com/pfizer-announces-topline-phase-2b-results-of-oral-glp-1r-agonist-danuglipron-in-adults-with-obesity/ 2023-12-06T05:58:03+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2.webp https://thepharmadata.com/update-on-crystalize-evidence-trials/ 2023-12-06T05:52:17+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Update.webp https://thepharmadata.com/astrazeneca-advances-scientific-leadership-in-haematology-at-ash-2023/ 2023-12-06T05:50:20+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Leadership.webp https://thepharmadata.com/roche-announces-positive-phase-iii-results-for-inavolisib-combination-in-people-with-advanced-hormone-receptor-positive-her2-negative-breast-cancer-with-a-pik3ca-mutation/ 2023-12-06T05:47:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp